Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D4VLI7
|
|||
| Drug Name |
JNJ-67484703
|
|||
| Synonyms |
JNJ-4703
Click to Show/Hide
|
|||
| Indication | Rheumatoid arthritis [ICD-11: FA20; ICD-9: 729] | Phase 1 | [1] | |
| Company |
Janssen Research & Development Raritan, NJ
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04985812) A Multicenter, Double-blind, Placebo-controlled, Randomized, Multiple Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of JNJ-67484703 in Participants With Active Rheumatoid Arthritis. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.